John Terrill

John Terrill has extensive experience in financial and accounting roles. John is currently working as a Controller at RayzeBio since October 2021. Prior to that, they worked at Turning Point Therapeutics as a Controller from October 2018 to October 2021, where they played a key role in raising significant funding through IPOs and managed a team of seven.

Before their role at Turning Point Therapeutics, John worked as the Director of Finance and Accounting at FTD Companies from April 2018 to July 2018. John also served as an Assistant Controller at Inovio Pharmaceuticals Inc. from November 2017 to April 2018.

John spent a significant portion of their career at Orexigen Therapeutics, where they held various roles, including Controller from October 2017 to November 2017, Assistant Controller from March 2016 to October 2017, and Accounting Manager from June 2014 to March 2016.

Earlier in their career, John worked as a Financial Reporting Manager at Volcano Corporation from April 2013 to May 2014 and as a Manager, Consolidations at NuVasive from March 2009 to April 2013. John also worked as a Financial Reporting Manager at Overland Storage from September 2008 to March 2009, where they were responsible for SEC filings and compliance.

John started their career at KPMG LLP as a Senior Associate from January 2004 to August 2008. John gained experience in financial statement audits, analysis, and compliance with GAAP.

Lastly, John worked as a Staff Auditor at Levitz, Zacks & Ciceric, Certified Public Accountants from January 2003 to December 2003, where they performed financial statement audits and prepared financial statements.

John Terrill attended Shepherd University from 1995 to 2000, where they pursued a Bachelor of Science (B.S.) degree in Accounting. Prior to their enrollment at Shepherd University, John attended C. Milton Wright, but the specific duration of their education or any degrees or fields of study obtained there were not provided.